Recruiting PHASE1 INTERVENTIONAL 1-arm
NCT07139067
Phase I Clinical Study of YK1101 Injection for the Treatment of Advanced Solid Tumors (YK1101)
Sponsor: Peking University
Conditions
Advanced Solid Tumor Cancer
Interventions
YK1101 cells
Updated 1 time since 2025 Last updated: Aug 18, 2025 Started: Apr 27, 2025 Primary completion: Jul 1, 2026 Completion: Jul 1, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE1 trial investigates Advanced Solid Tumor Cancer and is currently actively recruiting participants. Peking University leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
1 version recorded Recruiting — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Peking University
- Yingkai Saiwei（Beijing）Biotechnology Co., Ltd
Data source: Peking University
For direct contact, visit the study record on ClinicalTrials.gov .